Bundamedik Tbk vs Metro Healthcare Indonesia Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Metro Healthcare Indonesia Tbk. trades at Rp428 (market cap 14.23T, 346.3K 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 9.4× Bundamedik Tbk's market cap, and Bundamedik Tbk is more actively traded (536.7K versus 346.3K). Which is the better fit depends on your goals.
| BMHS | CARE | |
|---|---|---|
Market Cap | 1.51T | 14.23T |
Volume | 536.7K | 346.3K |
Lot | 5.37K | 3.46K |
Turnover | 93.41M | 147.93M |
Average Price | 174.05 | 427.18 |
Value | 93.41M | 147.93M |
Indicative Equilibrium Price | 176 | 428 |
Indicative Equilibrium Volume | 100 | 10 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →